Condition: Stroke · Ischemic Attack, Transient · Sponsor: Centre Hospitalier Universitaire de Nīmes
The main objective of this study is to compare two post-stroke/TIA (transient ischemic attack) imaging strategies in terms of the number of clinically important (i.e. requiring specific treatment according to current recommendations) lesions detected. The first strategy is the current/usual strategy in each participating centre and the second strategy consists in starting the post-stroke/TIA imaging assessment by a whole-body, low-dose angiography and subsequently resorting to elements of the usual strategy if required.
This description comes directly from the study's public registry record.
Francesco Macri, MD · +33.(0)6.19.42.18.52 · francesco.macri@chu-nimes.fr
Carey Suehs, PhD · +33.(0)4.66.68.67.88 · carey.suehs@chu-nimes.fr
Always discuss trial participation with your own doctor first.
| CHRU de Montpellier - Hôpital Gui de Chauliac | Montpellier, France | Recruiting |
| CHRU de Nîmes - Hôpital Universitaire Carémeau | Nîmes, France | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02662751